EZN-2968

· Enzon Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EZN-2968, covering 2011-07-07 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases [Phase 1]

See pricing